α-1 antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8

Journal of Clinical Investigation

Volumn 120, Issue 12, 2010, Pages 4236-4250

  Bergin, David A ^a   Reeves, Emer P ^a   Meleady, Paula ^b   Henry, Michael ^b   McElvaney, Oliver J ^a   Carroll, Tomás P ^a   Condron, Claire ^a   Chotirmall, Sanjay H ^a   Clynes, Martin ^b   O'Neill, Shane J ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CALCIUM ION; CD16 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; F ACTIN; FLOTILLIN 1; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; INTERLEUKIN 8; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; ANTIGEN ANTIBODY COMPLEX; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CELL FRACTIONATION; CELL MIGRATION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID RAFT; NEUTROPHIL CHEMOTAXIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADAM PROTEINS; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANTIGEN-ANTIBODY COMPLEX; CASE-CONTROL STUDIES; CHEMOTAXIS, LEUKOCYTE; GPI-LINKED PROTEINS; HUMANS; INTERLEUKIN-8; MEMBRANE MICRODOMAINS; MIDDLE AGED; MODELS, IMMUNOLOGICAL; MUTATION; NEUTROPHILS; RECEPTORS, IGG; RECEPTORS, INTERLEUKIN-8A; RECOMBINANT PROTEINS;

EID: 78649816539     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI41196     Document Type: Article

References (81)

1. Nita IM, Serapinas D, Janciauskiene SM. Alpha1- Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro. Int J Biochem Cell Biol. 2007;39(6):1165-1176. (Pubitemid 46819133)
2. Subramaniyam D, et al. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int J Biochem Cell Biol. 2008;40(2):258-271.
3. Janciauskiene S, Larsson S, Larsson P, Virtala R, Jansson L, Stevens T. Inhibition of lipopolysaccharide- mediated human monocyte activation, in vitro, by alpha1-antitrypsin. Biochem Biophys Res Commun. 2004;321(3):592-600.
4. Stockley RA, Shaw J, Afford SC, Morrison HM, Burnett D. Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis. Am J Respir Cell Mol Biol. 1990;2(2):163-170.
5. Petrache I, et al. Alpha-1 antitrypsin inhibits caspase- 3 activity, preventing lung endothelial cell apoptosis. Am J Pathol. 2006;169(4):1155-1166.
6. Rooney CP, Taggart C, Coakley R, McElvaney NG, O'Neill SJ. Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin. Am J Respir Cell Mol Biol. 2001;24(6):747-754.
7. Carlson JA, et al. Accumulation of PiZ alpha 1- antitrypsin causes liver damage in transgenic mice. J Clin Invest. 1989;83(4):1183-1190.
8. Perlmutter DH, Schlesinger MJ, Pierce JA, Punsal PI, Schwartz AL. Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease. J Clin Invest. 1989;84(5):1555-1561.
9. Miller SD, et al. Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of Bad. Hepatology. 2007;46(2):496-503.
10. McElvaney NG. Proteases and lung injury. In: Crystal RG, Weibel ER, Barnes PJ, eds. The Lung: Scientific Foundations. New York, New York, USA: Raven Press, Inc.; 1997:2205-2219.
11. Taggart CC, Greene CM, Carroll TP, O'Neill SJ, McElvaney NG. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. Am J Respir Crit Care Med. 2005; 171(10):1070-1076.
12. Wewers MD, et al. Replacement therapy for alpha 1- antitrypsin deficiency associated with emphysema. N Engl J Med. 1987;316(17):1055-1062. (Pubitemid 17047294)
13. Rouhani F, Paone G, Smith NK, Krein P, Barnes P, Brantly ML. Lung neutrophil burden correlates with increased pro-inflammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiency. Chest. 2000;117(5 suppl 1):250S-251S.
14. Malerba M, et al. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax. 2006;61(2):129-133.
15. du Bois RM, et al. Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-anti-trypsin. Blood. 1991;77(12):2724-2730.
16. Zerimech F, et al. Evaluation of a new Sebia isolectrofocusing kit for a1-antitrypsin phenotyping with the Hydrasys System. Clin Chem Lab Med. 2008; 46(2):260-263.
17. Gershagen S, Janciauskiene S. ELISA for specific detection of PiZ-related alpha(1)-antitrypsin deficiency. Clin Chem. 2004;50(12):2407-2410. (Pubitemid 39552188)
18. Kelly E, Greene CM, Carroll TP, McElvaney NG, O'Neill SJ. Selenoprotein S/SEPS1 modifies endoplasmic reticulum stress in Z variant {alpha}1-antitrypsin deficiency. J Biol Chem. 2009; 284(25):16891-16897.
19. Middelhoven PJ, Ager A, Roos D, Verhoeven AJ. Involvement of a metalloprotease in the shedding of human neutrophil Fc gammaRIIIB. FEBS Lett. 1997;414(1):14-18.
20. Coxon A, et al. Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity. 2001;14(6):693-704.
21. Kew RR, Grimaldi CM, Furie MB, Fleit HB. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl- leucyl-phenylalanine-induced chemotaxis. J Immunol. 1992;149(3):989-997.
22. Rhein LM, Perkins M, Gerard NP, Gerard C. FcgammaRIII is protective against Pseudomonas aeruginosa pneumonia. Am J Respir Cell Mol Biol. 2008; 38(4):401-406.
23. Schaff U, Mattila PE, Simon SI, Walcheck B. Neutrophil adhesion to E-selectin under shear promotes the redistribution and co-clustering of ADAM-17 and its proteolytic substrate L-selectin. J Leukoc Biol. 2008;83(1):99-105.
24. Kuschert GS, et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry. 1999;38(39):12959-12968.
25. Marshall LJ, et al. Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J Immunol. 2003;171(4):2057-2065.
26. Reeves EP, et al. IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis. J Immunol. 2010;184(3):1642-1652.
27. Lane HC, Anand AR, Ganju RK. Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis. Int Immunol. 2006; 18(8):1315-1325.
28. Schaff UY, Yamayoshi I, Tse T, Griffin D, Kibathi L, Simon SI. Calcium flux in neutrophils synchronizes beta2 integrin adhesive and signaling events that guide inflammatory recruitment. Ann Biomed Eng. 2008;36(4):632-646.
29. Grogan A, et al. Cytosolic phox proteins interact with and regulate the assembly of coronin in neutrophils. J Cell Sci. 1997;110(pt 24):3071-3081.
30. Westlin WF, Kiely JM, Gimbrone MA Jr. Interleukin- 8 induces changes in human neutrophil actin conformation and distribution: relationship to inhibition of adhesion to cytokine-activated endothelium. J Leukoc Biol. 1992;52(1):43-51.
31. Bucurenci N, Blake DR, Chidwick K, Winyard PG. Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett. 1992;300(1):21-24.
32. Janciauskiene SM, Nita IM, Stevens T. Alpha1- antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem. 2007;282(12):8573-8582. (Pubitemid 47093518)
33. Lu Y, et al. Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum Gene Ther. 2006;17(6):625-634.
34. Daemen MA, et al. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation. 2000;102(12):1420-1426.
35. Bylund J, et al. Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils. BMC Cell Biol. 2004;5:21.
36. Edwards SW. Biochemistry And Physiology Of The Neutrophil. Cambridge, United Kingdom: Cambridge University Press; 1994.
37. Woolhouse IS, Bayley DL, Lalor P, Adams DH, Stockley RA. Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease. Eur Respir J. 2005;25(4):612-617. (Pubitemid 40528752)
38. Proudfoot AE, et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A. 2003;100(4):1885-1890.
39. Solic N, Wilson J, Wilson SJ, Shute JK. Endothelial activation and increased heparan sulfate expression in cystic fibrosis. Am J Respir Crit Care Med. 2005;172(7):892-898. (Pubitemid 41369074)
40. Schumacher C, Clark-Lewis I, Baggiolini M, Moser B. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A. 1992;89(21):10542-10546.
41. Wuyts A, Proost P, Lenaerts JP, Ben-Baruch A, Van Damme J, Wang JM. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell- derived neutrophil attractant-78. Eur J Biochem. 1998;255(1):67-73.
42. Kurdowska A, et al. Specific binding of IL-8 to rabbit alpha-macroglobulin modulates IL-8 function in the lung. Inflamm Res. 2000;49(11):591-599.
43. Lucattelli M, et al. Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respir Res. 2005;6:83.
44. Travis J, et al. Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor. J Biol Chem. 1985;260(7):4384-4389. (Pubitemid 15092918)
45. Wencker M, Fuhrmann B, Banik N, Konietzko N. Longitudinal follow-up of patients with alpha(1)- protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest. 2001;119(3):737-744. (Pubitemid 32197642)
46. Lieberman J. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest. 2000;118(5):1480-1485.
47. Dirksen A, et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med. 1999;160(5 pt 1):1468-1472.
48. Pujazon MC, Carles P. [Augmentation therapy with alpha-1 antitrypsin:20 year- follow-up of a deficient patient]. Rev Mal Respir. 2008;25(9):1136-1141.
49. Paakko P, Kirby M, du Bois RM, Gillissen A, Ferrans VJ, Crystal RG. Activated neutrophils secrete stored alpha 1-antitrypsin. Am J Respir Crit Care Med. 1996;154(6 pt 1):1829-1833.
50. Kolarich D, Weber A, Turecek PL, Schwarz HP, Altmann F. Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics. 2006;6(11):3369-3380. (Pubitemid 43886153)
51. Campbell EJ, Owen CA. The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J Biol Chem. 2007;282(19):14645-14654.
52. Meknache N, Jonsson F, Laurent J, Guinnepain MT, Daeron M. Human basophils express the glycosylphosphatidylinositol- anchored low-affinity IgG receptor FcgammaRIIIB (CD16B). J Immunol. 2009;182(4):2542-2550.
53. Fernandes MJ, et al. CD16b associates with highdensity, detergent-resistant membranes in human neutrophils. Biochem J. 2006;393(pt 1):351-359.
54. Edberg JC, Kimberly RP. Modulation of Fc gamma and complement receptor function by the glycosylphosphatidylinositol- anchored form of Fc gamma RIII. J Immunol. 1994;152(12):5826-5835.
55. Huizinga TW, et al. The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature. 1988;333(6174):667-669.
56. Middelhoven PJ, Van Buul JD, Hordijk PL, Roos D. Different proteolytic mechanisms involved in Fc gamma RIIIb shedding from human neutrophils. Clin Exp Immunol. 2001;125(1):169-175. (Pubitemid 32703381)
57. Galon J, et al. Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16). Eur J Immunol. 1998;28(7):2101-2107.
58. Long C, Wang Y, Herrera AH, Horiuchi Dagger K, Walcheck B. In vivo role of leukocyte ADAM-17 in the inflammatory and host responses during E. coli-mediated peritonitis. J Leukoc Biol. 2010; 87:1097-1101.
59. Brynskov J, et al. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut. 2002;51(1):37-43.
60. Churg A, et al. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest. 2001;81(8):1119-1131.
61. Churg A, Wang RD, Xie C, Wright JL. Alpha-1- Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med. 2003;168(2):199-207. (Pubitemid 36920974)
62. Lewis EC, et al. Alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci U S A. 2008;105(42):16236-16241.
63. Reeves EP, et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002;416(6878):291-297.
64. Watson F, Gasmi L, Edwards SW. Stimulation of intracellular Ca2+ levels in human neutrophils by soluble immune complexes. Functional activation of FcgammaRIIIb during priming. J Biol Chem. 1997;272(29):17944-17951. (Pubitemid 27306370)
65. Weathington NM, et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med. 2006;12(3):317-323.
66. Marx N, et al. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol. 2004;24(3):540-545.
67. Guichard C, et al. Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem. 2005;280(44):37021-37032.
68. Dahlgren C, Karlsson A, Sendo F. Neutrophil secretory vesicles are the intracellular reservoir for GPI- 80, a protein with adhesion-regulating potential. J Leukoc Biol. 2001;69(1):57-62.
69. Morgan CP, Sengelov H, Whatmore J, Borregaard N, Cockcroft S. ADP-ribosylation-factor-regulated phospholipase D activity localizes to secretory vesicles and mobilizes to the plasma membrane following N-formylmethionyl-leucyl-phenylalanine stimulation of human neutrophils. Biochem J. 1997;325(pt 3):581-585.
70. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem. 1996;271(16):9690-9697.
71. Jayachandran R, et al. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell. 2007;130(1):37-50. (Pubitemid 47031320)
72. Lawless MW, Greene CM, Mulgrew A, Taggart CC, O'Neill SJ, McElvaney NG. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency. J Immunol. 2004;172(9):5722-5726.
73. Hinson ER, Cresswell P. The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion. J Biol Chem. 2009; 284(7):4705-4712.
74. Mahadeva R, et al. Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol. 2005; 166(2):377-386.
75. Li Z, Alam S, Wang J, Sandstrom CS, Janciauskiene S, Mahadeva R. Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema. Am J Physiol Lung Cell Mol Physiol. 2009;297(2):L388-400.
76. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature. 1992;357(6379):605-607.
77. Lomas DA, Mahadeva R. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest. 2002;110(11):1585-1590. (Pubitemid 35424233)
78. Mahadeva R, Dafforn TR, Carrell RW, Lomas DA. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem. 2002;277(9):6771-6774.
79. Sivasothy P, Dafforn TR, Gettins PG, Lomas DA. Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. J Biol Chem. 2000;275(43):33663-33668.
80. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1- proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem. 1980;255(9):3931-3934.
81. Taggart C, et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem. 2000;275(35):27258-27265.